The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR

Bioorg Med Chem Lett. 2012 Mar 1;22(5):2033-42. doi: 10.1016/j.bmcl.2012.01.023. Epub 2012 Jan 18.

Abstract

Herein the discovery of a novel class of aminoheterocyclic Na(v)1.7 antagonists is reported. Hit compound 1 was potent but suffered from poor pharmacokinetics and selectivity. The compact structure of 1 offered a modular synthetic strategy towards a broad structure-activity relationship analysis. This analysis led to the identification of aminopyrazine 41, which had vastly improved hERG selectivity and pharmacokinetic properties.

MeSH terms

  • Amines / chemistry
  • Amines / metabolism
  • Amines / pharmacokinetics
  • Amines / pharmacology
  • Animals
  • Drug Discovery
  • Inhibitory Concentration 50
  • Male
  • NAV1.7 Voltage-Gated Sodium Channel
  • Plasma / metabolism
  • Pyrazines / chemistry*
  • Pyrazines / metabolism
  • Pyrazines / pharmacokinetics
  • Pyrazines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Channel Blockers / chemistry*
  • Sodium Channel Blockers / metabolism
  • Sodium Channel Blockers / pharmacokinetics
  • Sodium Channel Blockers / pharmacology*
  • Sodium Channels / metabolism*
  • Structure-Activity Relationship

Substances

  • Amines
  • NAV1.7 Voltage-Gated Sodium Channel
  • Pyrazines
  • SCN9A protein, human
  • Sodium Channel Blockers
  • Sodium Channels